Related Experiment Video
Updated: Jan 15, 2026

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
Published on: May 22, 2020
Highly Active Strontium Peroxide Nanoparticles Induce Alkalization/Oxidation to Potentiate Cancer Immuno-Metabolic
Qiu-Yi Duan1, Liying Wang1, Xi Cheng1
1Shanghai Tenth People's Hospital, Shanghai Frontiers Science Center of Nanocatalytic Medicine, the Institute for Biomedical Engineering & Nano Science, School of Medicine, Tongji University, Shanghai 200072, P. R. China.
Strontium peroxide nanoparticles (SrPN) combat hepatocellular carcinoma (HCC) by reversing tumor acidosis and boosting immune response. This novel strategy enhances anti-cancer immunity for effective tumor destruction.
Area of Science:
- Biomedical Engineering
- Cancer Research
- Immunology
Background:
- Hepatocellular carcinoma (HCC) presents a significant health challenge due to its immunosuppressive tumor microenvironment (TME) and acidosis.
- Current treatments struggle to overcome the TME's poor immunogenicity and metabolic dysregulation.
- Targeting the TME's metabolic and immune characteristics is crucial for effective HCC therapy.
Purpose of the Study:
- To develop an oxidation-alkalization strategy for immuno-metabolic regulation in HCC.
- To induce immunogenic cell death (ICD) and enhance anti-cancer immune responses.
- To investigate the role of lactic acid in modulating the immune response within the TME.
Main Methods:
- Synthesis of strontium peroxide nanoparticles (SrPN) via a mild liquid-phase approach.
- Utilizing SrPN to induce oxidative stress and alkalization in HCC cells.
- Evaluating SrPN efficacy in an orthotopic HCC model using ultrasound-guided percutaneous injection.
Main Results:
- SrPN effectively induced ICD in HCC cells, promoting dendritic cell maturation and M1 macrophage polarization.
- Alkalization reversed tumor-induced acidosis, while H2O2-mediated oxidative stress enhanced immune responses.
- Lactic acid amplified macrophage glycolytic levels, synergizing with SrPN to promote M1 polarization and anti-cancer immunity.
- SrPN demonstrated high tumor inhibition efficiency in vivo through combined cancer cell killing and TME immuno-metabolic regulation.
Conclusions:
- The developed oxidation-alkalization strategy using SrPN shows promise for potentiating HCC anti-cancer immunity.
- Metabolic regulation within the TME, leveraging intratumoral metabolites like lactic acid, is key to enhancing therapeutic outcomes.
- SrPN offers a biocompatible and effective approach for immuno-metabolic regulation in HCC treatment.
More Related Videos
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...

